Workers on daily probiotics less likely to take time off sick

November 06, 2005

Workers who take probiotics daily are less likely to be off work with common illnesses, such as colds and gastroenteritis, than workers who don't. An exploratory study published today in the open access journal Environmental Health shows that workers who took a daily dose of the probiotic bacteria Lactobacillus reuteri were 2.5 times less likely to take sick leave than workers who took a placebo.

Py Tubelius, from Tetra Pak Occupational Health and Safety AB, and colleagues from BioGaia AB, in Lund, Sweden, conducted a study to assess the health benefits for adults of taking L. reuteri on a daily basis. A group of 181 staff (128 day workers and 53 shift workers) at the Tetra Pak factory in Lund agreed to take part in the study. The workers were randomly assigned at the start of the study, to receive a drink with or without L. reuteri, every day for a period of 80 days.

Twenty-three of the 87 workers in the group that took a placebo reported taking sick days during the 80 day-long study. In contrast, only 10 of the 94 workers that took L. reuteri reported taking any sick days during the study. The effect of L. reuteri was most significant in shift workers: none of the 26 shift workers in the reuteri group reported taking any sick leave, compared to nine out of 27 shift workers in the placebo group.
-end-
Article: Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study Py Tubelius, Vlaicu Stan, Anders Zachrisson Environmental Health: A Global Access Science Source, 2005, In press

BioMed Central

Related Placebo Articles from Brightsurf:

Effect of fluvoxamine vs placebo on clinical deterioration in outpatients with symptomatic COVID-19
This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects, versus placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reaction-confirmed mild COVID-19 illness.

Hydroxychloroquine no more effective than placebo in preventing COVID-19
Clinical trial with COVID-19 testing of participants shows health care workers in contact with coronavirus patients who took hydroxychloroquine each day did not reduce their rate of infection.

Compared to placebo, vitamin D has no benefit for severe asthma attacks
Contrary to earlier observational results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

UMN trial shows hydroxychloroquine has no benefit over placebo in preventing COVID-19
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

The placebo effect and psychedelic drugs: tripping on nothing?
A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone.

Methotrexate reduces joint damage progression over placebo in erosive hand OA
According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients.

Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain.

Probiotic no better than placebo for acute gastroenteritis in children
While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo.

Most common shoulder operation is no more beneficial than placebo surgery
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.

Read More: Placebo News and Placebo Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.